drug: tolcapone
- Clinical class: Anti-Parkinsonian (in combination with levodopa-carbidopa)
- Action: catechol-o-methyltransferase (COMT) inhibitor
- CSA schedule: none
- DEA number: none
- MEDLINEplus® Drug Information
U.S. Preparations:
- Tasmar® (Hoffmann-La Roche, Inc.) FDA approved indications: adjunct to levodopa and carbidopa for the treatment of the signs and symptoms of idiopathic Parkinson's disease (1.29.98) U.S. Product Information | USDA Consumer Drug Information
